Abstract
The production of 'global' metabolite profiles involves measuring low molecular-weight metabolites (<1 kDa) in complex biofluids/tissues to study perturbations in response to physiological challenges, toxic insults or disease processes. Information-rich analytical platforms, such as mass spectrometry (MS), are needed. Here we describe the application of ultra-performance liquid chromatography–MS (UPLC–MS) to urinary metabolite profiling, including sample preparation, stability/storage and the selection of chromatographic conditions that balance metabolome coverage, chromatographic resolution and throughput. We discuss quality control and metabolite identification, as well as provide details of multivariate data analysis approaches for analyzing such MS data. Using this protocol, the analysis of a sample set in 96-well plate format, would take ca. 30 h, including 1 h for system setup, 1–2 h for sample preparation, 24 h for UPLC–MS analysis and 1–2 h for initial data processing. The use of UPLC–MS for metabolic profiling in this way is not faster than the conventional HPLC-based methods but, because of improved chromatographic performance, provides superior metabolome coverage.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nicholson, J.K., Lindon, J.C. & Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181–1189 (1999).
Nicholson, J.K., Connelly, J., Lindon, J.C. & Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153–161 (2002).
Fiehn, O. Metabolomics—the link between genotypes and phenotypes. Plant. Mol. Biol. 48, 155–171 (2002).
Nicholson, J.K. & Lindon, J.C. Systems biology: metabonomics. Nature 455, 1054–1056 (2008).
Wishart, D.S. Applications of metabolomics in drug discovery and development. Drugs R. D. 9, 307–322 (2008).
Clarke, C.J. & Haselden, J.N. Metabolic profiling as a tool for understanding mechanisms of toxicity. Toxicol. Pathol. 36, 140–147 (2008).
Bollard, M.E. et al. Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol. Appl. Pharmacol. 204, 135–151 (2005).
Lindon, J.C., Holmes, E. & Nicholson, J.K. Metabonomics in pharmaceutical R&D. FEBS J. 274, 1140–1151 (2007).
Coen, M., Holmes, E., Lindon, J.C. & Nicholson, J.K. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem. Res. Toxicol. 21, 9–27 (2008).
Hinkelbein, J. et al. Alterations in cerebral metabolomics and proteomic expression during sepsis. Curr. Neurovasc. Res. 4, 280–288 (2007).
Bertini, I. et al. The metabonomic signature of celiac disease. J. Proteome. Res. 8, 170–177 (2009).
Gowda, G.A. et al. Metabolomics-based methods for early disease diagnostics. Expert. Rev. Mol. Diagn. 8, 617–633 (2008).
Lenz, E.M. et al. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J. Pharm. Biomed. Anal. 36, 841–849 (2004).
Gieger, C. et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 4, e1000282 (2008).
Holmes, E. et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453, 396–400 (2008).
Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2, 2692–2703 (2007).
Gika, H.G., Theodoridis, G. & Wilson, I.D. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine. Sample stability under different handling and storage conditions for metabonomics studies. J. Chromatogr. A 1189, 314–322 (2008).
Want, E.J. et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 78, 743–752 (2006).
Michopoulos, F., Lai, L., Gika, H., Theodoridis, G. & Wilson, I.D. UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. J. Proteome. Res. 8, 2114–2121 (2009).
Zelena, E. et al. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal. Chem. 81, 1357–1364 (2009).
Barton, R.H., Nicholson, J.K., Elliott, P. & Holmes, E. High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. Int. J. Epidemiol. 37 (Suppl 1): i31–i40 (2008).
Lauridsen, M., Hansen, S.H., Jaroszewski, J.W. & Cornett, C. Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage. Anal. Chem. 79, 1181–1186 (2007).
Matuszewski, B.K., Constanzer, M.L. & Chavez-Eng, C.M. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 70, 882–889 (1998).
Gangl, E.T., Annan, M.M., Spooner, N. & Vouros, P. Reduction of signal suppression effects in ESI-MS using a nanosplitting device. Anal. Chem. 73, 5635–5644 (2001).
Gustavsson, S.A., Samskog, J., Markides, K.E. & Långström, B. Studies of signal suppression in liquid chromatography-electrospray ionization mass spectrometry using volatile ion-pairing reagents. J. Chromatogr. A 937, 41–47 (2001).
Jellum, E. Profiling of human body fluids in healthy and diseased states using gas chromatography and mass spectrometry, with special reference to organic acids. J. Chromatogr. 143, 427–462 (1977).
Taylor, N.F. Urinary steroid profiling. Methods Mol. Biol. 324, 159–175 (2006).
Halket, J.M et al. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J. Exp. Botany 56, 219–243 (2005).
New, L.S. & Chan, E.C. Evaluation of BEH C18, BEH HILIC, and HSS T3 (C18) column chemistries for the UPLC-MS-MS analysis of glutathione, glutathione disulfide, and ophthalmic acid in mouse liver and human plasma. J. Chromatogr. Sci. 46, 209–214 (2008).
Wilson, I.D. et al. High resolution 'ultra performance' liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome. Res. 4, 591–598 (2005).
Tolstikov, V.V. & Fiehn, O. Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry. Anal. Biochem. 301, 298–307 (2002).
Idborg, H., Zamani, L., Schuppe-Koistinen, I. & Jacobsson, S. Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 828, 9–13 (2005).
Cubbon, S., Bradbury, T., Wilson, J. & Thomas-Oates, J. Hydrophilic interaction chromatography for mass spectrometric metabonomic studies of urine. Anal. Chem. 79, 8911–8918 (2007).
Gika, H.G., Theodoridis, G.A. & Wilson, I.D. Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. J. Sep. Sci. 31, 1598–1608 (2008).
Plumb, R.S. et al. A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130, 844–849 (2005).
Kind, T., Tolstikov, V., Fiehn, O. & Weiss, R.H. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal. Biochem. 363, 185–195 (2007).
Guy, P.A., Tavazzi, I., Bruce, S.J., Ramadan, Z. & Kochhar, S. Global metabolic profiling analysis on human urine by UPLC-TOFMS: issues and method validation in nutritional metabolomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871, 253–260 (2008).
Plumb, R.S. et al. Generation of ultrahigh peak capacity LC separations via elevated temperatures and high linear mobile-phase velocities. Anal. Chem. 78, 7278–7283 (2006).
Gika, H.G., Theodoridis, G., Extance, J., Edge, A.M. & Wilson, I.D. High temperature-ultraperformance liquid chromatography–mass spectrometry for the metabonomic analysis of Zucker rat urine. J. Chrom. B. 871, 279–287 (2008).
Lenz, E.M., Bright, J., Knight, R., Wilson, I.D. & Major, H. A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependant changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst 129, 535–541 (2004).
Nordström, A., Want, E., Northen, T., Lehtiö, J. & Siuzdak, G. Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Anal. Chem. 80, 421–429 (2008).
Leandro, C.C., Hancock, P., Fussell, R.J. & Keely, B.J. Ultra-performance liquid chromatography for the determination of pesticide residues in foods by tandem quadrupole mass spectrometry with polarity switching. J. Chromatogr. A 1144, 161–169 (2007).
Want, E.J., Nordström, A., Morita, H. & Siuzdak, G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J. Proteome. Res. 6, 459–468 (2007).
Plumb, R.S. et al. UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun. Mass Spectrom. 20, 1989–1994 (2006).
Bateman, K.P. et al. MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun. Mass Spectrom. 21, 1485–1496 (2007).
Crockford, D.J. 1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies. Anal. Chem. 80, 6835–6844 (2008).
Perry, R.H., Cooks, R.G. & Noll, R.J. Orbitrap mass spectrometry: instrumentation, ion motion and applications. Mass Spectrom. Rev. 27, 661–699 (2008).
Gika, H.G., Theodoridis, G.A., Wingate, J.E. & Wilson, I.D. Within day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J. Proteome. Res. 6, 3291–3303 (2007).
Gika, H.G., Macpherson, E., Theodoridis, G. & Wilson, I.D. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J. Chromatogr. B 871, 299–305 (2008).
Baker, J.M. et al. A metabolomic study of substantial equivalence of field-grown genetically modified wheat. Plant Biotechnol. J. 4, 381–392 (2006).
Sangster, T., Major, H., Plumb, R., Wilson, A.J. & Wilson, I.D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 131, 1075–1078 (2006).
FDA Guidance for Industry, Bioanalytical method Validation, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), May 2001.
Viswanathan, C.T. et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 24, 1962–1973 (2007).
Pham-Tuan, H., Kaskavelis, L., Daykin, C.A. & Janssen, H. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. J. Chromatogr. B 789, 283–301 (2003).
Smith, C.A., Want, E.J., O'Maille, G., Abagyan, R. & Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779–787 (2006).
Katajamaa, M., Miettinen, J. & Oresic, M. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22, 634–636 (2006).
Duran, A.L., Yang, J., Wang, L.J. & Sumner, L.W. Metabolomics spectral formatting, alignment and conversion tools (MSFACTs). Bioinformatics 19, 2283–2293 (2003).
Baran, R. et al. MathDAMP: a package for differential analysis of metabolite profiles. BMC Bioinformatics 7, 530–538 (2006).
Broeckling, C.D., Reddy, I.R., Duran, A.L., Zhao, X.C. & Sumner, L.W. MET-IDEA: data extraction tool for mass spectrometry-based metabolomics. Anal. Chem. 78, 4334–4341 (2006).
Katajamaa, M. & Oresic, M.J. Data processing for mass spectrometry-based metabolomics. Chromatogr. A 1158, 318–328 (2007).
Sumner, L.W., Urbanczyk-Wochniak, E. & Broeckling, C.D. Metabolomics data analysis, visualization, and integration. Methods Mol. Biol. 406, 409–436 (2007).
Ruan, Q. et al. An integrated method for metabolite detection and identification using a linear ion trap/Orbitrap mass spectrometer and multiple data processing techniques: application to indinavir metabolite detection. J. Mass. Spectrom. 43, 251–261 (2008).
Zhang, N.R. et al. Quantitation of small molecules using high-resolution accurate mass spectrometers—a different approach for analysis of biological samples. Rapid Commun. Mass Spectrom. 23, 1085–1094 (2009).
Ohta, D., Shibata, D. & Kanaya, S. Metabolic profiling using Fourier-transform ion-cyclotron-resonance mass spectrometry. Anal. Bioanal. Chem. 389, 1469–1475 (2007).
Crockford, D.J. et al. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal. Chem. 78, 363–371 (2006).
Wishart, D.S. et al. HMDB: the human metabolome database. Nucleic Acids Res. 35 (Database issue): D521–D526 (2007).
Wishart, D.S. et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37 (Database issue): D603–D610 (2009).
Smith, C.A. et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747–751 (2005).
Draper, J. et al. Metabolite signal identification in accurate mass metabolomics data with MZedDB, an interactive m/z annotation tool utilising predicted ionisation behaviour 'rules'. BMC Bioinformatics 10, 227 (2009).
Wilson, I.D. & Nicholson, J.K. Solid-phase extraction chromatography and nuclear magnetic resonance spectroscopy for the identification and isolation of drug metabolites in urine. Anal. Chem. 59, 2830–2832 (1987).
Baranyi, M., Milusheva, E., Vizi, E.S. & Sperlágh, B. Chromatographic analysis of dopamine metabolism in a Parkinsonian model. J. Chromatogr. A 1120, 13–20 (2006).
Gavaghan, C.L. et al. Directly coupled high-performance liquid chromatography and nuclear magnetic resonance spectroscopy with chemometric studies on metabolic variation in Sprague-Dawley rats. Anal. Biochem. 291, 245–252 (2001).
Spraul, M., Hofmann, M., Dvortsack, P., Nicholson, J.K. & Wilson, I.D. High-performance liquid chromatography coupled to high-field proton nuclear magnetic resonance spectroscopy: application to the urinary metabolites of ibuprofen. Anal. Chem. 65, 327–330 (1993).
Dear, G.J. et al. Mass directed peak selection, an efficient method of drug metabolite identification using directly coupled liquid chromatography-mass spectrometry-nuclear magnetic resonance spectroscopy. J. Chromatogr. B Biomed. Sci. Appl. 748, 281–293 (2000).
Lin, Y., Schiavo, S., Orjala, J., Vouros, P. & Kautz, R. Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Anal. Chem. 80, 8045–8054 (2008).
Shockcor, J.P. et al. Combined HPLC, NMR spectroscopy, and Ion-trap mass spectrometry with application to the detection and characterisation of xenobiotic and endogenous metabolites in human urine. Anal. Chem. 68, 4431–4435 (1996).
Nicholls, A.W, Wilson, I.D., Godejohann, M., Nicholson, J.K. & Shockcor, J.P. Identification of phenacetin metabolites in human urine after administration of phenacetin-C2H3: measurement of futile metabolic deacetylation via HPLC/MS-SPE-NMR and HPLC-ToF MS. Xenobiotica 36, 615–629 (2006).
Spraul, M. et al. Advancing NMR sensitivity for LC-NMR-MS using a cryoflow probe: application to the analysis of acetaminophen metabolites in urine. Anal. Chem. 75, 1536–1541 (2003).
Shockcor, J.P., Unger, S.E., Savina, P., Nicholson, J.K. & Lindon, J.C. Application of directly coupled LC-NMR-MS to the structural elucidation of metabolites of the HIV-1 reverse-transcriptase inhibitor BW935U83. J. Chromatogr. B Biomed. Sci. Appl. 748, 269–279 (2000).
Acknowledgements
The author E. Want acknowledges funding support from Waters Corporation. H. Gika acknowledges support from the European Committee through a European Reintegration Grant (ERG 202132).
Author information
Authors and Affiliations
Contributions
All authors contributed extensively to the work presented in this paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Want, E., Wilson, I., Gika, H. et al. Global metabolic profiling procedures for urine using UPLC–MS. Nat Protoc 5, 1005–1018 (2010). https://doi.org/10.1038/nprot.2010.50
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2010.50
This article is cited by
-
Quartet metabolite reference materials for inter-laboratory proficiency test and data integration of metabolomics profiling
Genome Biology (2024)
-
Integrated metabolome and transcriptome analysis provides insight into the leaf color change of Cymbidium ensifolium
Acta Physiologiae Plantarum (2024)
-
Prostaglandin A3 regulates the colony development of Odontotermes formosanus by reducing worker proportion
Crop Health (2024)
-
A comprehensive multiomics approach reveals that high levels of sphingolipids in cardiac cachexia adipose tissue are associated with inflammatory and fibrotic changes
Lipids in Health and Disease (2023)
-
Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization
Scientific Reports (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.